Diabetic Foot Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The diabetic foot ulcers clinical trial analysis report provides top line data relating to the clinical trials on diabetic foot ulcers. It includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country, phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials.
What is the regional outlook of the diabetic foot ulcers clinical trials market?
The diabetic foot ulcers clinical trials market is the largest in the Asia Pacific region followed by North America, Europe, the Middle East and Africa, and South and Central America. In terms of country, as of March 2022, the US has the highest number of diabetic foot ulcers clinical trials, followed by Iran, China, India, Germany, United Kingdom, Sweden, Italy, Poland, and Russia. Poland has the highest average patient enrollment.
Diabetic foot ulcers clinical trials market in G7 countries
Among the G7 (the US, the UK, Germany, France, Italy, Canada, and Japan) countries, the US has the highest proportion of diabetic foot ulcers to metabolic disorders clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority was in the US.
Diabetic foot ulcers clinical trials market in E7 countries
Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia has the highest proportion of diabetic foot ulcers to metabolic disorders clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority was in China.
Diabetic foot ulcers clinical trials market, by region
For more regional insights, download a free report sample
What are the key sponsor types in the diabetic foot ulcers clinical trials market?
The key sponsor types in the diabetic foot ulcers clinical trials market are institution, company, and government. Out of them, institution dominates the market.
Diabetic foot ulcers clinical trials market, by sponsor types
For more sponsor type insights, download a free report sample
Which are the key companies in the diabetic foot ulcers clinical trials market?
The key companies in the diabetic foot ulcers clinical trials market are Smith & Nephew Plc, Anterogen Co Ltd, Integra LifeSciences Holdings Corp, Innocoll Holdings Ltd, CytoTools AG, Pfizer Inc, Oneness Biotech Co Ltd, ArcticZymes Technologies ASA, F. Hoffmann-La Roche Ltd, and Dipexium Pharmaceuticals Inc.
Diabetic foot ulcers clinical trials market, by key companies
To know more about key companies, download a free report sample
Market report scope
|
Key regions |
Asia-Pacific, Northern America, Europe, Middle East and Africa, and South and Central America |
| Key sponsor types | Institution, Company, and Government |
| Key companies | Smith & Nephew Plc, Anterogen Co Ltd, Integra LifeSciences Holdings Corp, Innocoll Holdings Ltd, CytoTools AG, Pfizer Inc, Oneness Biotech Co Ltd, ArcticZymes Technologies ASA, F. Hoffmann-La Roche Ltd, and Dipexium Pharmaceuticals Inc |
The report provides:
- A snapshot of the global clinical trials landscape.
- Top level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end point status.
- Reviews of top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- All the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for unaccomplishment.
- Enrollment trends for the past five years.
- Latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional and country level.
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The key regions in the diabetic foot ulcers clinical trials market are Asia-Pacific, North America, Europe, Middle East and Africa, and South and Central America.
The key sponsor types in the diabetic foot ulcers clinical trials market are institution, company, and government.
The key companies in the diabetic foot ulcers clinical trials market are Smith & Nephew Plc, Anterogen Co Ltd, Integra LifeSciences Holdings Corp, Innocoll Holdings Ltd, CytoTools AG, Pfizer Inc, Oneness Biotech Co Ltd, ArcticZymes Technologies ASA, F. Hoffmann-La Roche Ltd, and Dipexium Pharmaceuticals Inc.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Metabolic Disorders reports